Home Applications 213725 Application 213725
Type ANDA
Sponsor SUN PHARM Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 PANTOPRAZOLE SODIUM PANTOPRAZOLE SODIUM FOR SUSPENSION, DELAYED RELEASE;ORAL EQ 40MG BASE No No
Source provenance: Browse the complete Orange Book source catalog · source snapshot 45 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A213725-001 PANTOPRAZOLE SODIUM PANTOPRAZOLE SODIUM EQ 40MG BASE FOR SUSPENSION, DELAYED RELEASE / ORAL AB 2020-06-30
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A213725-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 2 of 2 · 41 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A213725-001 PANTOPRAZOLE SODIUM EQ 40MG BASE FOR SUSPENSION, DELAYED RELEASE / ORAL AB 2020-06-30 a50c72e98297…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 41 observed states.
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2021-12-28 21:50 UTC 2021-12 A213725-001 PC 2021-02-09 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A213725-001 PC 2021-02-09 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A213725-001 PC 2021-02-09 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A213725-001 PC 2021-02-09 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A213725-001 PC 2021-02-09 c0c555d07b60…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 2 matching rows.
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 4 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 62756-071 PANTOPRAZOLE SODIUM PANTOPRAZOLE SODIUM Sun Pharmaceutical Industries, Inc. ANDA Current 62756-071 PANTOPRAZOLE SODIUM PANTOPRAZOLE SODIUM Sun Pharmaceutical Industries, Inc. ANDA Current 62756-071 PANTOPRAZOLE SODIUM PANTOPRAZOLE SODIUM Sun Pharmaceutical Industries, Inc. ANDA Current 62756-071 PANTOPRAZOLE SODIUM PANTOPRAZOLE SODIUM Sun Pharmaceutical Industries, Inc. ANDA Current
Documents# Document, Submission type, Date table Document Submission type Date 64390 ORIG 2020-08-24